Update on Quadrivalent Meningococcal Vaccines available in Canada

The purpose of this Statement is to supplement previous conjugate meningococcal vaccine statements which have outlined the use of monovalent meningococcal C and quadrivalent conjugate meningococcal vaccines. This statement will review existing NACI recommendations on the use of conjugate meningococcal vaccines; update the epidemiology of meningococcal disease in Canada; and review and update information on quadrivalent conjugate meningococcal vaccines and vaccination schedules used in Canada.